Individualized medicine and the imperative of global health

Clinical Pharmacology and Therapeutics

Volumn 82, Issue 5, 2007, Pages 479-483

  Waldman, S A ^a   Terzic, A ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BIOTECHNOLOGY; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DIARRHEA; EDITORIAL; FINANCIAL MANAGEMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; MEASLES; MORBIDITY; MORTALITY; OBESITY; PANDEMIC; PRIORITY JOURNAL; PROGNOSIS; PUBLIC HEALTH; RESPIRATORY TRACT INFECTION; WORLD HEALTH ORGANIZATION;

BIOMEDICAL RESEARCH; BIOTECHNOLOGY; CARDIOVASCULAR DISEASES; COMMUNICABLE DISEASES; CULTURAL CHARACTERISTICS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DRUG THERAPY; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; INCIDENCE; NEOPLASMS; PHARMACEUTICAL PREPARATIONS; POLITICS; PUBLIC HEALTH; RESEARCH SUPPORT AS TOPIC; RESPIRATORY TRACT DISEASES; SOCIAL RESPONSIBILITY; TABOO; WORLD HEALTH;

EID: 35448952216     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100398     Document Type: Editorial

References (16)

1. Waldman, S.A., Christensen, N.B., Moore, J.E. & Terzic, A. Clinical pharmacology: the science of therapeutics. Clin. Pharmacol. Ther. 81, 3-6 (2007).
2. Piquette-Miller, M. & Grant, D.M. The art and science of personalized medicine. Clin. Pharmacol. Ther. 81, 311-315 (2007).
3. Global Health Council. Infectious Diseases 〈http://www.globalhealth. org/view_top.php3?id=228〉.
4. MMWR Morbid. Mortal. Wkly. Rep. 55, 841-844 (2006).
5. MMWR Morbid. Mortal. Wkly. Rep. 42, 49 (1993).
6. Zhang, Y. Advances in the treatment of tuberculosis. Clin. Pharmacol. Ther. 82, 595-600 (2007).
7. Global Health Reporting.org. Malaria: Overview 〈http://www. globalhealthreporting.org/malaria.asp〉.
8. Nyunt, M.M. & Plowe, C.V. Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance. Clin. Pharmacol. Ther. 82, 601-605 (2007).
9. Levenson, J.W., Skerrett, P.J. & Gaziano, J.M. Reducing the global burden of cardiovascular disease: the role of risk factors. Prev. Cardiol. 5, 188-199 (2002).
10. World Health Organization. Global Cancer Rates Could Increase by 50% to 15 Million by 2020 〈http://www.who.int/mediacentre/news/releases/2003/pr27/ en〉.
11. Cohen-Kohler, J.C. The morally uncomfortable global drug gap. Clin. Pharmacol. Ther. 82, 610-614 (2007).
12. Robertson, J. & Hill, S.R. The essential medicines list for a global patient population. Clin. Pharmacol. Ther. 82, 498-500 (2007).
13. Cortese, D.A. A vision of individualized medicine in the context of global health. Clin. Pharmacol. Ther. 82, 491-493 (2007).
14. Reidenberg, M.M. Essential medicines for the whole world. Clin. Pharmacol. Ther. 82, 500-503 (2007).
15. Zucker, H. & Rägo, L. Access to essential medicines for children: the World Health Organization's global response. Clin. Pharmacol. Ther. 82, 503-505 (2007).
16. Waldman, S.A., Terzic, M.R. & Terzic, A. Molecular medicine hones therapeutic arts to science. Clin. Pharmacol. Ther. 82, 343-347 (2007).